PMC

Depiction of “reverse translation” whereby we start by conducting immunotherapy clinical trials in patients to obtain appropriate tumor tissues and blood samples for exploratory studies, which enables hypothesis generation and subsequent experiments in animal models for hypothesis testing, with data from both the patients and animals providing a greater understanding and leading to development of more effective therapies.